LUMICKS Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 263

Employees

  • Latest Deal Type
  • Series D

  • Latest Deal Amount
  • $93M

  • Investors
  • 14

LUMICKS General Information

Description

Developer of dynamic single-molecule and cell avidity analysis instruments designed to reveal unique molecular and cellular interactions. The company's technology permits the disruptive techniques of live measurement and imaging of interactions at the single-molecule level, which is key for the prevention and cure of cancer and other diseases, enabling researchers to get insight into the fundamental cause of disease and potential for drug optimization.

Contact Information

Website
www.lumicks.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Decision/Risk Analysis
Corporate Office
  • Paalbergweg 3
  • 1105 AG Amsterdam
  • Netherlands
+31 020 000 0000

LUMICKS Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

LUMICKS Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series D) 15-Apr-2021 $93M 000.00 Completed Generating Revenue
7. Later Stage VC 01-Sep-2020 00.000 00.000 Completed Generating Revenue
6. Grant 18-Mar-2020 00.000 Completed Generating Revenue
5. Early Stage VC 01-Dec-2017 Completed Generating Revenue
4. Grant 24-Jan-2017 00.000 Completed Generating Revenue
3. Grant 12-May-2015 Completed Startup
2. Grant 22-Jan-2015 $297K Completed Startup
1. Accelerator/Incubator Completed Startup
To view LUMICKS’s complete valuation and funding history, request access »

LUMICKS Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of dynamic single-molecule and cell avidity analysis instruments designed to reveal unique molecular and cellu
Biotechnology
Amsterdam, Netherlands
263 As of 2023
000.00
00000000000 000.00

000000

eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt i
0000000000 000000000
Munich, Germany
00 As of 0000
000.00
000000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

LUMICKS Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Dynamic Biosensors Venture Capital-Backed Munich, Germany 00 000.00 000000000000 000.00
You’re viewing 1 of 1 competitors. Get the full list »

LUMICKS Patents

LUMICKS Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210372928-A1 Microscopy method and system Pending 17-Dec-2018 00000000000 00

LUMICKS Executive Team (14)

Name Title Board Seat Contact Info
Gijs Oude Elberink Chief Operating Officer
Mattijs de Groot Chief Technology Officer
Andrea Candelli Ph.D Co-Founder, Chief Scientific Officer & Head of Sales and Commercial Business Development
Hugo De Wit CEO
Edmée Verhulp CFO
You’re viewing 5 of 14 executive team members. Get the full list »

LUMICKS Board Members (10)

Name Representing Role Since
Alex Slack Lauxera Capital Partners Board Member 000 0000
Don Kania Ph.D Self Chairman 000 0000
Melissa McLaughlin Self Board Member 000 0000
Peter van den Broek Self Board Member 000 0000
Pieter Van der Meer Gilde Healthcare Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

LUMICKS Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

LUMICKS Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Farallon Capital Management Hedge Fund Minority 000 0000 000000 0
Irving Investors Growth/Expansion Minority 000 0000 000000 0
Lauxera Capital Partners Growth/Expansion Minority 000 0000 000000 0
Parian Global Management Hedge Fund Minority 000 0000 000000 0
Pura Vida Investments Hedge Fund Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »

LUMICKS FAQs

  • When was LUMICKS founded?

    LUMICKS was founded in 2014.

  • Who is the founder of LUMICKS?

    Olivier Heyning, Andrea Candelli Ph.D, Gijs Wuite Ph.D, and Erwin Peterman Ph.D are the founders of LUMICKS.

  • Where is LUMICKS headquartered?

    LUMICKS is headquartered in Amsterdam, Netherlands.

  • What is the size of LUMICKS?

    LUMICKS has 263 total employees.

  • What industry is LUMICKS in?

    LUMICKS’s primary industry is Biotechnology.

  • Is LUMICKS a private or public company?

    LUMICKS is a Private company.

  • What is LUMICKS’s current revenue?

    The current revenue for LUMICKS is 00000.

  • How much funding has LUMICKS raised over time?

    LUMICKS has raised $97.9M.

  • Who are LUMICKS’s investors?

    Farallon Capital Management, Irving Investors, Lauxera Capital Partners, Parian Global Management, and Pura Vida Investments are 5 of 14 investors who have invested in LUMICKS.

  • Who are LUMICKS’s competitors?

    Dynamic Biosensors is a competitor of LUMICKS.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »